Cytomegalovirus in Solid Organ Transplantation

Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation

(2013) Scott M. Palmer   ANNALS OF INTERNAL MEDICINE

Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis

(2012) Guy Boivin et al.   JOURNAL OF CLINICAL VIROLOGY

Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis

(2012) A.P. Wiita et al.   Transplant Infectious Disease

Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment

(2012) Elena Beam et al.   Current Infectious Disease Reports

First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246

(2011) D. R. Kaul et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials

(2011) D. C. Brennan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cyclopropavir Susceptibility of Cytomegalovirus DNA Polymerase Mutants Selected after Antiviral Drug Exposure

(2011) Sunwen Chou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroEvaluation of the Activities of the Novel Anticytomegalovirus Compound AIC246 (Letermovir) against Herpesviruses and Other Human Pathogenic Viruses

(2011) Manfred Marschall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation

(2011) Dana G. Wolf et al.   ANTIVIRAL RESEARCH

Factors Contributing to Variability of Quantitative Viral PCR Results in Proficiency Testing Samples: a Multivariate Analysis

(2011) R. T. Hayden et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: A single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial

(2011) C. Ashley Finlen Copeland et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

(2011) T. Goldner et al.   JOURNAL OF VIROLOGY

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

(2011) Paul D Griffiths et al.   LANCET

The risk of cytomegalovirus recurrence after kidney transplantation

(2011) Ilkka Helanterä et al.   TRANSPLANT INTERNATIONAL

Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients

(2011) Hans-Arne Myhre et al.   TRANSPLANTATION

Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia

(2011) Luiz F. Lisboa et al.   TRANSPLANTATION

Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial

(2011) Oliver Witzke et al.   TRANSPLANTATION

Progress in the development of new therapies for herpesvirus infections

(2011) Nathan B Price et al.   Current Opinion in Virology

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

(2010) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004

(2010) Sheri Lewis Bate et al.   CLINICAL INFECTIOUS DISEASES

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

(2010) Albert J. Eid et al.   DRUGS

Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection

(2010) Michael J. Cannon et al.   REVIEWS IN MEDICAL VIROLOGY

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

(2010) R.K. Avery et al.   Transplant Infectious Disease

Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study

(2010) Atul Humar et al.   TRANSPLANTATION

Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes

(2010) Robin K. Avery et al.   TRANSPLANTATION

The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response

(2010) Luiz F. Lisboa et al.   TRANSPLANTATION

Interlaboratory Comparison of Cytomegalovirus Viral Load Assays

(2009) X. L. Pang et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients

(2009) A. J. Eid et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients

(2009) D. Kumar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

(2009) A. Åsberg et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Direct and indirect effects of cytomegalovirus: can we prevent them?

(2009) Raymund Razonable   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

An Assessment of Donor‐to‐Recipient Transmission Patterns of Human Cytomegalovirus by Analysis of Viral Genomic Variants

(2009) Oriol Manuel et al.   JOURNAL OF INFECTIOUS DISEASES

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection

(2009) Albert J Eid et al.   TRANSPLANT INTERNATIONAL

Prophylaxis Followed by Preemptive Therapy Versus Preemptive Therapy for Prevention of Human Cytomegalovirus Disease in Pediatric Patients Undergoing Liver Transplantation

(2009) Giuseppe Gerna et al.   TRANSPLANTATION

Improvement in Long-Term Renal Graft Survival due to CMV Prophylaxis with Oral Ganciclovir: Results of a Randomized Clinical Trial

(2008) V. Kliem et al.   AMERICAN JOURNAL OF TRANSPLANTATION

An Assessment of Herpesvirus Co-infections in Patients with CMV Disease: Correlation with Clinical and Virologic Outcomes

(2008) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation

(2008) N.W. Cummins et al.   Transplant Infectious Disease